MaxCyte MXCT Accrued expenses and other liabilities
Accrued expenses and other liabilities at other companies
Other financials
Where this comes from
Reported directly by MaxCyte in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesAndOtherLiabilities.
The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about MaxCyte's accrued expenses and other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MaxCyte's accrued expenses and other liabilities?
- MaxCyte (MXCT) reported accrued expenses and other liabilities of $4.37M in Q1 2026.
- How has MaxCyte's accrued expenses and other liabilities changed year-over-year?
- MaxCyte's accrued expenses and other liabilities decreased by 13.2% year-over-year, from $5.03M to $4.37M.
- What is the long-term trend for MaxCyte's accrued expenses and other liabilities?
- Over 5 years (2020 to 2025), MaxCyte's accrued expenses and other liabilities has grown at a 8.0% compound annual growth rate (CAGR), from $5.31M to $7.81M.